Metabolic (cytoprotective) therapy of menopausal disturbances

The paper presents modern views on cardiovascular aspects of menopause and metabolic therapy of menopausal disturbances with meldonium (Mildronate®). The role of estrogen deficiency in climacteric disturbance development, key pathogenetic mechanisms of menopausal metabolic syndrome (MS), and relevan...

Full description

Bibliographic Details

Published in:	Кардиоваскулярная терапия и профилактика
Main Authors:	S. N. Tolstov, V. B. Mychka
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 2011-06-01
Subjects:	menopause menopausal metabolic syndrome arterial hypertension metabolic therapy mildronate
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1835